NEVRO CORP. Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements
NEVRO CORP. reported Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements of 0 shares for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Notes
us-gaap:IncrementalCommonSharesAttributableToShareBasedPaymentArrangements · last filed 2025-03-04
- NEVRO CORP. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2023-09-30 was 0.00 shares, a 100.00% decline year-over-year.
- NEVRO CORP. incremental common shares attributable to dilutive effect of share-based payment arrangements for the quarter ending 2022-09-30 was 129.72K shares.
- NEVRO CORP. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2024 was 0.00 shares.
- NEVRO CORP. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2023 was 0.00 shares, a 100.00% decline from fiscal 2022.
- NEVRO CORP. incremental common shares attributable to dilutive effect of share-based payment arrangements for fiscal 2022 was 207.61K shares.
| Period end | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 3 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 9 month | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements 12 month |
|---|---|---|---|
| 2024-12-31 | 0.00 shares 10-K · filed 2025-03-04 | ||
| 2023-12-31 | 0.00 shares 10-K · filed 2025-03-04 | ||
| 2023-09-30 | 0.00 shares 10-Q · filed 2023-11-01 | 0.00 shares 10-Q · filed 2023-11-01 | |
| 2022-12-31 | 207.61K shares 10-K · filed 2025-03-04 | ||
| 2022-09-30 | 129.72K shares 10-Q · filed 2023-11-01 | 236.42K shares 10-Q · filed 2023-11-01 |